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Characterization of Adrenergic Receptors in Human 
Cerebral Arteries and the Alteration after 
Subarachnoid Hemorrhage 
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Department of Neurosurgery, Faculty of Medicine, Kyoto University 
(Director: Prof. Dr. HAJIME HANDA) 
The nature of adrenergic receptors in human cerebral arteries was characterized and the 
changes of these receptors after subarachnoid hemorrhage was examined using a radioligand 
binding assay. 3H-prazosin司aselective alpha 1 antagoni,t, binding was performed by incubating 
aliquots of the cerebral arterial homogenates. Specific binding of increasing concentrations of 
3H-prazosin was saturable. Scatchard plot indicated a single class of binding sites, with Kn= 
2 nM and Bmax=60 fmol/mg protein. 3H-yohimbine, a selective alpha 2 antagonist, binding 
was performed. Specific binding of increasing concentrations of aH-yohimbine was saturable. 
Scatchard plot of the saturation curve was curvilinear. Computer analysis of the data indicated 
two cl出町、、 ofbinding sites, with Kn=0.5 nM, Bmax=20 fmol/mg protein and Kn=30 nM. 
Bmax=250 fmol/mg protein, respectively. Specific 3H-dihydroalprenolol, a beta adrenergic 
antagonist, binding was saturable with Kn=12 nM and Bmax=790 fmol/mg protein. The 
analysis of inhibition of specific 3H-dihydroalprenolol binding by adrenergic agentぉsuggested
that human cerebral arteri肘 containa high density of beta adrenergic receptors and that the 
receptors are classified into two types, namely beta 1 and beta 2 adrenergic receptors. The 
calculated ratio of beta 1 : beta 2 was approximately 4 : 6. Seate、hardplot of 3H-prazosin 
binding to human cerebral arteries after subarachnoid hemorrhage was also of single class with 
slightly smaller Bmax, and Kn became about half of that of control group. 3H-Yohimbine 
Key words: Human cerebral arteries, Alpha adrenergic receptors, Beta adrenergic receptors，メubarachnoid
hemorrhage, Receptor binding assay. 
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binding to the arteries after subarachnoid hemorrhage was of single cla州、 thoughit was of two 
clases in the control group. High a伍nitysites of alpha 2 adrenergic receptors討eemto disappear 
and both Ko and Bmax of low affinity sites of alpha 2 adrenergic receptors became large after 
subarachnoid hemorrage. Ko and Bmax of 3H-dihydroalprenolol binding after subarachoid 
hemorrhage were 14 nM and llOO fmol/mg protein, respectively. The calculated ratio of 
beta 1 : beta 2 ratio was approximately 6 : 4. These data suggest that sympathe位、 denervation
occurs in the cerebral arteries after subarachnoid hemorrhage and that postsynaptic alpha 1 
adrenergic receptors becom巴sensitiveto catecholamines. These functional changes of sympathe-















































今回，私たちは， m アドレナリン遮断薬である＇ H-


























7.4）中で glass homogenizer を用いて細切した．
homogenate を2枚のガーゼを通して漉過後， poly・ 





















液 8mlを含む vial中に移した.sH－放射線量を Pac-
kard Tri-Carb scintillation spectrometer (Model 3255) 
により測定した．阻害曲線を得るために，解離定数lζ





















MICRO 7 Computerを用い分析した.3H-yohimbine 
結合， 3H-DHA結合はいずれも Olsenらが記載した









!-adrenaline bitartrate, yohimbine hydrochloride 
（半井，京都）， /-noradrenaline bitartrate, (Sigma, 
St. Louis, USA), prazosin hydrochloride (C1b.1 
Geigy, Basel, Switzerland), butoxamine (Bur-







3H-prazosin (speci五cactivity 80.9 Ci/mmol), 31-1-
yohimbine (specific activity 89.7 Ci/mmol), 3H-DHA 
(specific activity 34.1 Ci/mmol）は NewEngland 




ことが明らかとなった．高親和性部位の Ko1,Bmax 1 
はそれぞれ0.5 1:VI, 20 fmol/mg protein であり， (J ＼｛~1















線の Seatehard解析は直線上に示され， 3H-DHλ の結









3H-yohimbine の特異的結合は反応f夜中の "l-1・ 
himbine濃度増加lとしたがつて飽和性を示した（Fig.
2）目飽和曲線の Sじatchard解析は曲線上lこ示され，コ
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Fi昌.1. Saturation of soec1五c'H prazosin binding to human cerebral arteries of non・ 
討AHcases. 吋：e《l 3l-J；即osinbir ng，加ermir】edas d回 er din the tピ，；t
IS p]o町 dfor in~reasing concentrations of added 3H -prazosin. Each point岬 re・
sents the mean of 6川 1SAH cases. The ir t sho、、•s d 
from the mean of the sι1tur：ι1ti《】ncurve. 'I、heslope of the plot、弘isdetermine 《l 








れ2nM, 60 fmol/mg protein であった（Fig.1). 









































Fig. 2. Saturation of speci抗c3H-yohimbine binding to human cerebral arteries of non-
日AHcases. Each point represents the mean of 6-non-SAH cases. The inset 
shows the Scatchard plot of the saturation curve. The slope of the plot was 
determined by nonlinear regression analysis. 















































ト＇aturはt1tmof speci日c3H-DHA binding to human cerebral arteries of non-SAH 
cases. Each point represents the mean of 4-non-SAH cases. The inset shows 
the Scatchard plot of the saturation curve. The slope of the plot was determined 




Table 1. I<‘，1 values of various drugs inhibiting寸l-prazosin,3H-yohimbine 
and 3H-DHA binding to human cerebral arteries. Each value is 
the mean of 3 non-SAH 仁川出 IC加 isthe concentration of drugs 
that reduces the specific bindings by 50%. 
Drug 
lCso (JLM) 


















より 3H-prazosin 結合の Ko, Bmaxを算出した．
Kn; lnM, Bmax・ 50fmol/mg proteinであり，対照
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Fig. 4. Hofstee plots for the displacement curves of 
3H-DHA binding by selective beta 1 (meto-
prolol) and beta 2 (butoxamine) antagoni-
sts; non-SAH group （・Ian d日AHgroup 
(O). Each point represents the mean of 3-














































Fig. 5. ト；，1turalin11of speci品c3H-prazosin binding to human cerebral arteries of SAH 
cas刊 Eachpoint represents the mean of 5-SAH cases. The inset shows the 
Scatchard plot of the saturation curve. The slope of the plot was determined by 


































































Saturation of speci品c3H-yohimbine binding to human cerebral arteries of SAH 
cases. Each point represents the mean of 5 SAH cases. The inset shows the 
Scatchard plot of the saturation curve. The slope of the plot was determined 
by linear regression analysis. 







































Fig. 7. Saturation of spec1凸c3H DHA binding to human cerebral arteries of S.¥ll 
cases. Each point represents the mean of 4-SAH cases. The inset shows the 
Scatchard plot of the saturation curve. The slope of the plot wa' determined 
by linear regression analysis. 
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